Connect with us

Houston Rockets

Will Carroll Q&A: Beverley’s knee remains a “fairly major concern” for Rockets

Will Carroll, a national sportswriter specializing in injuries and treatment, joins us to discuss the status of Patrick Beverley’s knee and his future.

Published

on

Patrick Beverley

Patrick Beverley may not be out of the woods yet when it comes to his troublesome right knee. After tearing the meniscus in late March and briefly reaggravating it in Game 1 of the playoffs vs. Portland, it remains a concern for both he and the Rockets as they map out his usage for the 2014-15 season.

With training camp approaching, the Rockets and Beverley are working together on a plan to manage and stabilize the knee and particularly the muscles surrounding it. Beverley, of course, opted against having any surgical procedure to correct the injury, instead returning to the court after just two weeks and playing an integral role in the team’s playoff run.

Beverley’s ability to avoid surgery was in contrast to many other high-profile athletes with meniscus tears, including Houston Texans rookie linebacker Jadeveon Clowney, who underwent surgery just this week and is expected to be out at least 4-to-6 weeks.

Will Carroll, lead writer of sports medicine at Bleacher Report and a long-established expert in the field of sports injuries, spoke to us and also joined the Red & Orange Report podcast to discuss how the Rockets may manage Beverley going forward. A transcript of our conversations is below:

Q: Ultimately, Pat ended up not choosing to go through with a surgical procedure. How much of a concern is this for Pat Beverley going forward?

A: It’s a fairly major concern. I know Daryl Morey and the staff there have calculated the odds, and they’ve gone with a very aggressive rehab protocol. They think they can stabilize that knee otherwise.

In pulling part of the meniscus or even in a repair, it’s not going to be exactly as it was. It’s going to change the internal structure of the knee. So what you have to do, if you can’t stabilize that portion, if you’re not putting it back as close to 100% as you can, you have to stabilize around it. In any sort of situation with that, that’s where you want to focus.

In early rehab, you want to work on those secondary stabilizers. If the muscles surrounding the knee are not only intact but strong, they can get that sense of where things are in space and when things are getting too taxed. If you’ve ever sprained your ankle, you felt it. You couldn’t do much. Athletes tend to have a much better proprioceptive and spatial sense about them. It’s part of their gift. So Beverley’s going to have to work really hard, and I’m sure he has, all the way up to and through training camp to get those stabilizers. He’s also going to have to not overtax himself to where his muscles are tired and cease to be the strong stabilizers that he’s going to need to protect that knee.

So the medical staff is going to have to work with the analytics staff, which is going to have to work with their sport science staff, to put everything together. This is going to be an amazing puzzle of human performance to keep him as healthy as they possibly can.

If you think about it, he’s going to have to do all the things he has to do athletically and within a team context on top of try to manage his own fatigue and manage his recovery and continue to do a rehab/prehab protocol throughout the entire season. In other words, Patrick Beverley’s going to be spending a whole lot of time with the medical staff. We don’t see that outside. That’s one of those things. It’s that invisible game of sports medicine and sports science and human performance that some people are putting hours and hours of their lives into. We don’t reward them. Most people don’t know who the athletic trainers and physical therapists are that get these athletes back on the field, but they’re an incredibly important part of any team.

Q: In general, what is the risk profile of someone with an untreated meniscus tear? Without accounting for the specifics of a team or player’s rehab plans, what are the general future problems that an NBA player playing with this injury might have?

A: It’s certainly risky, but the doctors feel it’s manageable, so I have to go with that. Mostly you see arthritis. It can get more serious where there’s grinding and has to be cleaned out or even microfracture. Down the line, knee replacement is possible, but that’s in the general population.

Q: Are the Rockets, as an organization, prepared for this?

A: I think where the Rockets might have an advantage is that they are a very data-driven team. They’ve been using the Skyview cameras, they’ve been using a lot of analytics, things like the Catapult system which tracks the players and their statistics such as heart rate and respiration, and I think with all that data, that’s going to give them an advantage in figuring out what Beverley can and cannot do and how to manage that properly.

Q: I know both the team and Pat himself are going to be on top of this. One of our good sources at ClutchFans said earlier this summer that Pat was contemplating going to Germany and trying some of those treatments. I don’t know that he actually did it — if he did, we never heard about it — but I know that he and the team are looking at contingencies. Would a minutes restriction help? If you play him 30-to-32 minutes per night instead of 38 minutes, is that something that may help him last longer?

A: Yeah, but that’s oversimplifying it a little bit. I don’t think that you’re wrong. If this were two years ago, my answer would’ve been ‘Yes, absolutely’. But again, with the amount of data that we have, the new data from the cameras, the sensors and the performance data we can get, things are changing. If you run him on an AlterG treadmill, which is one of those anti-gravity, air-pressure treadmills — I know Houston is one of the teams that has one — you’re going to be able to figure out what he can do. What kind of sprints can he run? Because basketball isn’t like running a 5K. You can go through a lot of information and work on a lot of things, and you can have him on court in practices and scrimmages and then figure this out.

So it would be simplistic, but not incorrect, to say that a minutes restriction could do that. But I think it’s going to be more than a minutes restriction. How is he going to be out there? Is it better for him to be out there for 4 minutes and then a rest, or is it better for 10 minutes and then come back? How does his knee react to that?

There are so many factors that just a few years ago, we wouldn’t have had access to. And now, because we have this emerging data, we’re going to have a better sense for it. You’re not wrong about a minutes restriction, but I think they’re going to be able to come up with an exceptionally-individualized program that’s going to make it better for him. Sensors and sensor data is one of the most exciting parts of sport science right now. And I think it’s absolutely amazing how fast it’s moving.

Q: Beverley is a free agent in July 2015. With the medical knowledge that teams have today, is there a chance that this lingering issue could impact his market value going forward?

A: Absolutely, but it should be a known quantity by then. It depends on where he goes. Some teams are better at managing things like this, and Houston’s one of them.

Houston Rockets

Poison Pill: The Impact of Recent Extensions on the Rockets’ Trade Options

Published

on

Just before the start of the regular season, the Houston Rockets signed Jalen Green to a three-year, $105.3 million extension and Alperen Sengun to a five-year, $185 million extension, locking up two key pieces of their rebuild. These extensions eliminated any meaningful salary cap room for Houston in the summer of 2025. However, since the NBA is trending away from key players changing teams via free agency (recent examples such as Paul George and the Rockets’ own Fred VanVleet notwithstanding), Rafael Stone and his team likely viewed the extensions as worth the risk.

The Rockets have positioned themselves as one of the league’s most interesting trade teams, as they boast a unique combination of good young players, premium future draft picks, and expiring salaries. But signing Green and Sengun to those extensions made trading each of those players this season significantly more difficult.

Article VII, Section 8(g) of the 2023 NBA Collective Bargaining Agreement – you know the one! – is more commonly known as the Poison Pill Provision, which relates to the trade treatment of players recently signed to rookie scale extensions. If a recently extended player is traded prior to the July 1 in which the extension kicks in, then while the player’s outgoing salary would be the same as his then current cap figure, the player’s incoming salary to the acquiring team would instead be the *average* of the player’s then current salary and all salaries during the extension. This makes any trade made under the Poison Pill Provisions exceedingly difficult.

Using Green and Sengun as examples, their respective outgoing and incoming salaries would be:

Jalen Green
Outgoing Salary for Houston: $12.5 million
Incoming Salary for Acquiring Team: $29.5 million

Alperen Sengun
Outgoing Salary for Houston: $5.4 million
Incoming Salary for Acquiring Team: $31.7 million

These vast discrepancies in outgoing and incoming salary treatment make Green and Sengun very difficult to trade, as most NBA trades must fall within salary-matching rules. While there are possible trade scenarios involving numerous players and salaries that could allow for Green or Sengun to be traded, most of those scenarios are unrealistic and/or would involve three or more teams and the expenditure of additional assets to get those additional teams to take on salaries.

The Rockets don’t seem to have much desire to move either Green or Sengun right now. However, if they do decide to move either of them, it would most likely not be until next July, when the Poison Pill Provision is no longer applicable and those players can be traded at their new extension salaries.

Continue Reading

Houston Rockets

Houston Rockets Draft Decisions: Who Will Be the #3 Pick?

Published

on

By

Houston Rockets Podcast

It’s officially NBA Draft Week!

The weeks of speculation are coming to an end as we’ve just about arrived at the 2024 NBA Draft. The Rockets hold picks #3 and #44 and could be quite active on the trade market.

Dave Hardisty and David Weiner paired up on the ClutchFans podcast to discuss the options before the Houston Rockets as they approach the June 26th NBA Draft. Is it really down to Donovan Clingan and Reed Sheppard as options? The pair also discuss trade-down options and whether Devin Carter could be intriguing to Ime Udoka. And are the Rockets a darkhorse for a Paul George trade?

The podcast premieres at 8:00am CT! Come join us!



CLUTCHFANS PODCAST: SPOTIFY | APPLE

Continue Reading

Houston Rockets

Podcast: Houston Rockets options with the #3 pick of the 2024 NBA Draft

Published

on

By

Houston Rockets 2024 NBA Draft prospects Zaccharie Risacher Stephon Castle Reed Sheppard Donovan Clingan

The offseason is now underway.

The forecast looks good for the Houston Rockets, but… there’s pressure as well this offseason because there are a handful of other West teams that might have rosier futures. Ime Udoka wants to win and win big. As we are about five weeks away from the NBA Draft, what are the Rockets looking to do this summer?

David Weiner joined Dave Hardisty on the ClutchFans podcast to discuss the Rockets shockingly landing the #3 pick and their options in this draft, including Reed Sheppard, Donovan Clingan, Zaccharie Risacher, Stephon Castle, Matas Buzelis and others. They also discuss the possibility of some big game hunting in Houston.


CLUTCHFANS PODCAST: SPOTIFY | APPLE

Continue Reading

Houston Rockets

Podcast: Steven Adams, Mikal Bridges and Trade Possibilities for the Rockets

Published

on

By

Houston Rockets Trade Deadline 2024

The Houston Rockets already made one deal, acquiring center Steven Adams from Memphis for a handful of second-round picks, but we still have several days left before this Thursday’s NBA Trade Deadline.

Are more deals on the way?

Rumors of interest in Mikal Bridges have swirled, with the Rockets holding precious (and unprotected) first-round picks from Brooklyn. They also could use some help inside this season, which Adams can not provide. Shooting is always in demand.

David Weiner joined Dave Hardisty on the ClutchFans podcast to discuss the Adams trade, its impact on the Rockets in 2024-25 and beyond, the Mikal Bridges rumors, the Brooklyn picks, other trade possibilities and options for Rafael Stone moving forward. Also discussed is the play of Houston’s core 6 prospects: Amen Thompson, Cam Whitmore, Alperen Sengun, Jabari Smith Jr., Tari Eason and Jalen Green.


CLUTCHFANS PODCAST: SPOTIFY | APPLE

Continue Reading

Houston Rockets

Rockets trade for center Steven Adams

Published

on

By

Steven Adams Houston Rockets

The Rockets made a surprise trade on Thursday, sending the contract of Victor Oladipo and three second-round picks to Memphis for center Steven Adams.

The deal came together quickly and the Rockets had a small window to get it done, hence why this trade was made with a week to go until the trade deadline.

The Price

When you consider that Memphis did this for cost savings primarily and that Adams would not play for any team in the league this season, the price seemed a little high to me. The Rockets gave up the OKC second-round pick this year, which is no big loss, but they also give up the better of Brooklyn’s or Golden State’s second-round pick this season. That’s a pretty good pick (likely in the late 30’s). They also give up the better of Houston’s or OKC’s second-round pick in 2025. If things go as planned for the Rockets, that pick should be in the 45-55 range.

But they didn’t sacrifice a first-round pick, which would have been brutal, and they were not going to use all those seconds this season. So it’s just a matter of opportunity cost — who else could they have gotten for this package?

My understanding is they (particularly Ime Udoka) are very high on Adams.

The Rockets also did this move for cap purposes as well. By moving out the Oladipo contract, which was expiring, and bringing in Adams’ deal, which is signed for $12.4M next season, the window for the Rockets to put together a trade package for a star player is extended out until the 2025 trade deadline. They continue to wait to see which players, if any, shake loose here and become available. They want flexible (see: expiring) contracts that they can combine with assets and this gives them another year to be in that position.

The Trade

It’s not often that the Rockets acquire a player I had not considered beforehand but that’s the case with Steven Adams. The Rockets sorely need a big with size that provides more traditional center strengths, making Clint Capela, Robert Williams, Nick Richards or Daniel Gafford potential candidates, but Adams was overlooked for a few reasons.

First, the 30-year old big man is out for the season after knee surgery cost him the entire 2023-24 campaign, so the Rockets won’t get any benefit from this trade this season. Secondly, Adams is not your traditional center either when it comes to rim protection.

But what Adams does do, he’s really good at and he has some of the same strengths of Brook Lopez, who the Rockets tried to sign in the offseason. Adams is quite possibly the strongest guy in the league and a legitimate 6-foot-11 with a 7-foot-5 wingspan. He’s an outstanding screen-setter, something that could really benefit the likes of Fred VanVleet, Amen Thompson and Jalen Green. He was also an elite rebounder last season, finishing 6th in the league in caroms at 11.5 a game despite playing just 27.0 minutes a contest.

After watching Jonas Valanciunas absolutely bully the Rockets inside on Wednesday, it should be apparent by now to everyone that this was a pretty big need.

In 2021-22, the Memphis Grizzlies finished #2 in the West at 56-26. Their top two players in Net Rating that season were Dillon Brooks (+11.0) and Adams (+8.3), key cogs in a defense that held opponents to 108.6 points per 100 possessions. They’re both now Houston Rockets.

So this adds another trusted vet to Ime Udoka’s rotation.

The question is will the 30-year old Adams return to form after the knee injury? Adams sprained the posterior cruciate ligament in his right knee a year ago, which cost him the end of that season and the playoffs. He tried rehabbing it and it never got better, so surgery became the option just as this season was kicking off.

I like to think the Rockets did their due diligence on that, despite the short time it took for this deal to come together, but that’s unclear.

If he does bounce back, then Udoka has a big man he can turn to reliably in situational matchups or on nights when the younger bigs struggle. He wouldn’t be Boban or even Jock Landale in that scenario — he’s going to play, so the frontcourt depth in 2024-25 should be better. In the end, they got a starting-caliber center who will have no problems coming off the bench, and that’s what they were looking for.

Continue Reading

Trending